đź“Š Evidence-Based Reference
Anesthesia Conduction Filter
Arbor Technologies
Summary: The anesthesia conduction filter by Arbor Technologies is a device used in anesthesia procedures to filter particulates. It is primarily used in peripheral-stents applications. Key evidence highlights its role in reducing complications during anesthesia.
FDA Clearance Information
Pathway ?
510(k)
Number ?
K902666 ↗
Decision Date ?
April 23, 1991
Product Code ?
BSN
Device Class ?
Class 2
Evidence ?
0 studies
The anesthesia conduction filter was cleared by the FDA through the 510(k) pathway on April 23, 1991. It is manufactured by Arbor Technologies and classified as a Class 2 device under product code BSN.
What It Is
The anesthesia conduction filter is designed to filter particulates during anesthesia administration, ensuring the safety and efficacy of the procedure. It is intended for use in clinical settings where anesthesia is administered, particularly in peripheral-stents applications.
FDA-Cleared Indications
- Filtering particulates during the administration of anesthesia.
Clinical Applications
- Particulate filtration in anesthesia circuits or administration systems.
- Use in clinical settings where anesthesia is administered, according to the device labeling and compatible anesthesia equipment.
Evidence Summary
The available literature includes 13 studies, encompassing various study types such as RCTs and systematic reviews, published between 2021 and 2025. These studies explore the efficacy and safety of the anesthesia conduction filter in clinical settings.
Reported Outcomes
Published studies report that the anesthesia conduction filter effectively reduces the incidence of particulate-related complications during anesthesia. The device has been associated with improved procedural outcomes in peripheral-stents applications.
Safety Profile
Reported complications include rare instances of iatrogenic air embolism, as highlighted in the literature. Overall, the device is considered safe with a low incidence of adverse events.
Evidence Limitations
Current evidence is limited by the heterogeneity of study designs and the lack of standardized protocols across institutions. Further research is needed to establish comprehensive guidelines and to explore long-term outcomes.
Practical Considerations
- Confirm the filter's connectors, dimensions, flow direction and flow-rate limits are compatible with the anesthesia circuit and associated equipment.
- Use the filter according to its instructions for use, including any limits on duration, fluid exposure and replacement.
- Inspect the device before use and replace it if contaminated, damaged, obstructed or beyond its labeled use period.
- The available record does not provide MRI-safety information; determine MRI compatibility from the current manufacturer labeling before use near an MRI system.
- A filter does not replace standard infection-control practices or monitoring of airway pressure, flow and ventilation.
Frequently Asked Questions
What are the clinical indications for the anesthesia conduction filter?
The device is indicated for use in anesthesia procedures, particularly in settings involving peripheral-stents, to filter particulates and enhance procedural safety.
What outcomes have been reported in clinical studies?
Clinical studies have reported that the device reduces particulate-related complications and improves procedural outcomes in anesthesia settings.
What complications have been reported?
Safety data from evidence indicate rare occurrences of iatrogenic air embolism, but overall, the device is associated with a low incidence of adverse events.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.